Recombinant factor VIIa concentrate versus plasma-derived concentrates for treating acute bleeding episodes in people with haemophilia and inhibitors. [PDF]
Matino D +4 more
europepmc +1 more source
Rational Use of Recombinant Factor VIIa in Clinical Practice. [PDF]
Dutta TK, Verma SP.
europepmc +1 more source
Pulmonary thromboembolism in Glanzmann Thrombasthenia: a case report and systematic literature review. [PDF]
Mohammad Alizade T +3 more
europepmc +1 more source
Recombinant factor VIIa addition to haemophilic blood perfused over collagen/tissue factor can sufficiently bypass the factor IXa/VIIIa defect to rescue fibrin generation. [PDF]
Li R +4 more
europepmc +1 more source
Recombinant factor VIIa as haemostatic therapy in advanced liver disease. [PDF]
Mannucci PM, Franchini M.
europepmc +1 more source
The Factor Approach: Coagulation Treatment Optimization and Recommendations (FACTOR). [PDF]
Leidy S, Mahmoudjafari Z.
europepmc +1 more source
Use of recombinant factor VIIa in uncontrolled gastrointestinal bleeding after hematopoietic stem cell transplantation among patients with thrombocytopenia. [PDF]
Tang Y +7 more
europepmc +1 more source
Outcomes of recombinant activated factor VIIa (NovoSeven) therapy in glanzmann thrombasthenia: two case reports. [PDF]
Almatar E, Alsharidah S, Hashem OA.
europepmc +1 more source

